Scotland backs NHS use of Alexion's Ultomiris for rare disea...

NHS patients in Scotland with the rare disease atypical haemolytic uremic syndrome (aHUS) will now be able to access treatment with Alexion's Ultomiris, ahead of their counterparts in Engla

CHMP backs Roche's Enspryng for rare nerve disease NMOSD

Roche's Enspryng has been recommended for approval in the EU for treating neuromyelitis optica spectrum disorder (NMOSD), extending the treatment options for people with the life-threatenin

Roche trumpets data for Soliris rival in NMOSD after US, EU ...

Roche preps filings for satralizumab in rare disease NMOSD

Alexion’s biosimilar-blocking EU patent play for Soliris fai...

Alexion’s Soliris follow-up Ultomiris snares EU approval